← Insider buys
GBT

Global Blood Therapeutics, Inc.

Director Charles J Homcy sold $2.7M of Global Blood Therapeutics, Inc.

Sold$2,708,469
$27.08Price
100,000Shares
−42%Stake

What GBT did after the filing

Prices for GBT after this filing aren't in yet.

Traded Thu, Jun 1. Filed Thu, Jun 22. Not investment advice.